Predictors of weight progression among HIV infected adults on anti-retroviral treatment in Mekelle hospital, Tigray, Ethiopia: A longitudinal study
PLOS One · 2025
DOI: 10.1371/journal.pone.0327392 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ataklti Kiflu Arefayne und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia. Hauptthemen laut MEDLINE: HIV Infections, Body Weight, Anti-Retroviral Agents. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Human immunodeficiency virus (HIV) remains a significant global public health issue, causing over 35 million deaths until 2017. In 2013, 24.7 million people in sub-Saharan Africa were living with HIV with 1.5 million new infections and 1.1 million deaths. Evidences on weight progression among HIV patients in low resource settings are limited. Additionally, many of the previously conducted studies were cross-sectional. Therefore, this study aimed to examine predictors of weight progression among adult HIV infected patients on ART from January 2017 to December 2019 in Mekelle hospital, Tigray, Ethiopia.
Methods
Retrospective longitudinal study was conducted from March 2, 2020 to March 14, 2020 at Mekelle General Hospital, Tigray, Ethiopia. A total of 97 individuals were followed every six months for two years. STATA version15 was used for data analysis. Linear mixed model was used to examine progression of weight after the baseline measurement. Regression coefficients of the final model and their 95% confidence intervals were used as measures of association with p-value below 0.05 indicating statistical significance.
Results
Baseline median age of participants was found to be 35 years (IQR = 27.5 to 40). At baseline, 39.18% were underweight, 53.61% normal and 7.22% overweight. About one-fifth (19.59%) of the study subjects were diagnosed with tuberculosis infection. Patients who had normal weight at baseline lost 1.89 kg (β = −1.89, 95% CI: −3.11, −0.66) at 6 months compared to underweight patients. Patients with CD4 level of >350 cells/µL at baseline lost 2.53 kg (β = −2.53, 95% CI: −4.43, −0.63) weight lower than patients with CD4 level of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia.
- Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Aksum University, Aksum, Tigray, Ethiopia.
ORCID-Profile: Hagazi Gebre Meles, Goitom Halefom Senbete, Yohannes Kinfe Gebreyohannes
Zitieren
APA
Arefayne, A. K., Meles, H. G., Senbete, G. H., Gebrelibanos, K. B., Gebrekorkos, L. M., & Gebreyohannes, Y. K. (2025). Predictors of weight progression among HIV infected adults on anti-retroviral treatment in Mekelle hospital, Tigray, Ethiopia: A longitudinal study. PLOS One. https://doi.org/10.1371/journal.pone.0327392
Vancouver
Arefayne AK, Meles HG, Senbete GH, Gebrelibanos KB, Gebrekorkos LM, Gebreyohannes YK. Predictors of weight progression among HIV infected adults on anti-retroviral treatment in Mekelle hospital, Tigray, Ethiopia: A longitudinal study. PLOS One. 2025. doi:10.1371/journal.pone.0327392
BibTeX
@article{Arefayne2025,
author = {Arefayne, Ataklti Kiflu and Meles, Hagazi Gebre and Senbete, Goitom Halefom and Gebrelibanos, Kibrom Birhane and Gebrekorkos, Letemichael Mezgebo and Gebreyohannes, Yohannes Kinfe},
title = {Predictors of weight progression among HIV infected adults on anti-retroviral treatment in Mekelle hospital, Tigray, Ethiopia: A longitudinal study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0327392}
}
EUVIMED